Cancer Diagnostics

A Cancer Blood Test should be more than yes no maybe. 

Get More.

Get more from your cancer blood tests with VDI Cancer Diagnostics

MORE…

  • Context-sensitive interpretation
  • Type-specific cancer panels
  • Insight to other concurrent diseases
  • Guidance when it’s NOT cancer
  • Patient support w/ Test & Treat solutions, supportive tests for the sick animal, and patient monitoring.
  • VALUE from a single blood test

VDI Blood Tests

SERVICENUMBER OF PARAMETERSINTENDED USE
Cancer Panel – General3ADR or suspicious mass
Cancer Panel – Lymphoma3Suspected LSA
Pre-Stem Cell Therapy Panel4Patient evaluation prior to stem cell therapy
Pericardial Effusion Panel2Suspected heart cancer
GI Lymphoma Panel5IBD vs GI LSA
Advanced GI Panel
(learn more)
12IBD, LSA, Pancreatitis, PLE, SIBO, Malabsorption, Dietary Deficiencies

Cancer Panel

Blood tests for the detection and management of suspected cancer


Cancer Panel

The Cancer panel is dual-marker blood test for diagnosing and managing cancer in a variety of tumor types in dogs and cats. Commonly used as a first-step diagnosis prior to, or in place of biopsy, the cancer panel can give you confidence that neoplasia is present, and if proceeding to more invasive costly workup or referral to specialists is warranted. After diagnosis is made, the Cancer Panel can be used to monitor disease progression or therapy outcomes.

Common Applications:

  • Lymphoma
  • Abdominal mass
  • Solid tumors
  • Mast Cell Tumors (stage II)
  • ADR dog/cat
  • Hypercalcemia of malignancy
  • Chemotherapy management
  • Post mass-removal confirmation
  • Metastatic Disease

Not recommended for:

  • Cutaneous masses
  • Mast Cell Tumors (stage I)
  • Brain tumors

Reports Include:

  • TK1 result
  • C-Reactive Protein (dog) or Haptoglobin (HPT) result
  • Neoplasia Index (NI)
  • Interpretive Comments
  • Contextual Review (must provide context on requisition form)

Sample Canine Reports:

Sample Feline Reports:


Pericardial Effusion Panel

The Canine Pericardial Effusion Panel uses TK1 from serum and pericardial fluid to determine if the source of the effusion is due to cancer. Neoplastic causes of PCE, particularly hemangiosarcoma, impart a significantly worse prognosis than non-neoplastic etiologies. Ratio of TK1 serum to pericardial fluid is able to rule-out cancer effectively. Contact VDI for more information on the Pericardial Effusion Panel.

GI Lymphoma Panel

Blood tests for the detection and management of suspected GI cancer

GI Lymphoma Panel

The GI Lymphoma Panel is a 4-marker panel used for the diagnosis of GI LSA in the acutely ill cat or dog. Cats are notorious for GI inflammatory disease, and it continues to be one of the harder determinations we see. As GI disease progresses if often times overlaps with the development of Lymphoma – making the differential determination challenging using ultrasound alone. Reluctance and inability to biopsy leaves diagnosis a guess. The GI LSA panel takes the guesswork out.

Applications:

  • GI Lymphoma
  • Chronic progressive IBD
  • ADR cat or dog
  • Chemotherapy management

Reports Include:

  • TK1 result
  • HPT (cat) or CRP (dog) result
  • B12/ Folate results
  • B12 dosing guidelines
  • Neoplasia Index (NI) GILSA
  • Interpretive Comments
  • Contextual Review (must provide context on requisition form)

Sample Reports:


Equine Lymphoma

Thymidine Kinase Type 1 – Equine Lymphoma Test

Thymidine Kinase Type 1 (TK1) is a DNA proliferation marker that has been shown in a number of human and animal studies to be highly elevated in Lymphoma. High cellular turnover, especially in aggressive & poorly differentiated lymphoma, gives lymphoma a robust TK1 response that is readily picked up in blood serum. Measurement of TK1 activity can be a rule-in for lymphoma in the suspected horse.